BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tsapralis D, Panayiotides I, Peros G, Liakakos T, Karamitopoulou E. Human epidermal growth factor receptor-2 gene amplification in gastric cancer using tissue microarray technology. World J Gastroenterol 2012; 18(2): 150-155 [PMID: 22253521 DOI: 10.3748/wjg.v18.i2.150]
URL: https://www.wjgnet.com/1007-9327/full/v18/i2/150.htm
Number Citing Articles
1
Hiroshi Yoshida, Noriko Yamamoto, Hirokazu Taniguchi, Ichiro Oda, Hitoshi Katai, Ryoji Kushima, Hitoshi Tsuda. Comparison of HER2 status between surgically resected specimens and matched biopsy specimens of gastric intestinal-type adenocarcinomaVirchows Archiv 2014; 465(2): 145 doi: 10.1007/s00428-014-1597-3
2
Hao Wu, Zhenzhai Cai, Guangrong Lu, Shuguang Cao, He Huang, Yi Jiang, Weijian Sun. Impact of c-erbB-2 Protein on 5-year Survival Rate of Gastric Cancer Patients after Surgery: A Cohort Study and Meta-analysisTumori Journal 2017; 103(3): 249 doi: 10.5301/tj.5000444
3
Narikazu Boku. HER2-positive gastric cancerGastric Cancer 2014; 17(1): 1 doi: 10.1007/s10120-013-0252-z
4
Julita Machlowska, Ryszard Maciejewski, Robert Sitarz. The Pattern of Signatures in Gastric Cancer PrognosisInternational Journal of Molecular Sciences 2018; 19(6): 1658 doi: 10.3390/ijms19061658
5
Fang Zhou, Wensheng Qiu, Lingling Sun, Jinyu Xiang, Xiaoxiao Sun, Aihua Sui, Aiping Ding, Lu Yue. Clinical significance of nucleophosmin/B23 and human epidermal growth factor receptor 2/neu expressions in gastric cancersAPMIS 2013; 121(7): 582 doi: 10.1111/apm.12043
6
Juhee Jeong, Duk Ki Kim, Ji-Hyeon Park, Do Joong Park, Hyuk-Joon Lee, Han-Kwang Yang, Seong-Ho Kong, Keehoon Jung. Tumor-Infiltrating Neutrophils and Non-Classical Monocytes May Be Potential Therapeutic Targets for HER2negative Gastric CancerImmune Network 2021; 21(4) doi: 10.4110/in.2021.21.e31
7
MELIKE DINCCELIK-ASLAN, GUVEM GUMUS-AKAY, ATILLA HALIL ELHAN, EKREM UNAL, AJLAN TUKUN. Diagnostic and prognostic significance of glypican 5 and glypican 6 gene expression levels in gastric adenocarcinomaMolecular and Clinical Oncology 2015; 3(3): 584 doi: 10.3892/mco.2015.486
8
Daisuke Kotani, Kohei Shitara. Trastuzumab deruxtecan for the treatment of patients with HER2-positive gastric cancerTherapeutic Advances in Medical Oncology 2021; 13: 175883592098651 doi: 10.1177/1758835920986518
9
Takahiro Ishii, Kohei Shitara. Trastuzumab deruxtecan and other HER2-targeting agents for the treatment of HER2-positive gastric cancerExpert Review of Anticancer Therapy 2021; : 1 doi: 10.1080/14737140.2021.1982698
10
A. Creemers, E. ter Veer, L. de Waal, P. Lodder, G. K. J. Hooijer, N. C. T. van Grieken, M. F. Bijlsma, S. L. Meijer, M. G. H. van Oijen, H. W. M. van Laarhoven. Discordance in HER2 Status in Gastro-esophageal Adenocarcinomas: A Systematic Review and Meta-analysisScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-03304-9
11
Maria Apicella, Simona Corso, Silvia Giordano. Targeted therapies for gastric cancer: failures and hopes from clinical trialsOncotarget 2017; 8(34): 57654 doi: 10.18632/oncotarget.14825
12
A. Ieni, V. Barresi, L. Rigoli, R. A. Caruso, G. Tuccari. HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the StomachDisease Markers 2015; 2015: 1 doi: 10.1155/2015/234851
13
Antonio Ieni, Roberta Cardia, Cristina Pizzimenti, Pio Zeppa, Giovanni Tuccari. HER2 Heterogeneity in Personalized Therapy of Gastro-Oesophageal Malignancies: An Overview by Different MethodologiesJournal of Personalized Medicine 2020; 10(1): 10 doi: 10.3390/jpm10010010
14
Qichun Wei, Jing Xu, Li Shen, Xianhua Fu, Bicheng Zhang, Xiaofeng Zhou, Jorgen Carlsson. HER2 expression in primary gastric cancers and paired synchronous lymph node and liver metastases. A possible road to target HER2 with radionuclidesTumor Biology 2014; 35(7): 6319 doi: 10.1007/s13277-014-1830-3
15
Shigehiro Koganemaru, Kohei Shitara. Antibody–drug conjugates to treat gastric cancerExpert Opinion on Biological Therapy 2021; 21(7): 923 doi: 10.1080/14712598.2020.1802423
16
Taroh Satoh, Rui-Hua Xu, Hyun Cheol Chung, Guo-Ping Sun, Toshihiko Doi, Jian-Ming Xu, Akihito Tsuji, Yasushi Omuro, Jin Li, Jin-Wan Wang, Hiroto Miwa, Shu-Kui Qin, Ik-Joo Chung, Kun-Huei Yeh, Ji-Feng Feng, Akihira Mukaiyama, Mikiro Kobayashi, Atsushi Ohtsu, Yung-Jue Bang. Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment ofHER2-Amplified Advanced Gastric Cancer in Asian Populations: TyTAN—A Randomized, Phase III StudyJournal of Clinical Oncology 2014; 32(19): 2039 doi: 10.1200/JCO.2013.53.6136
17
Chen Zeng, Ran Yan, Guanghua Yang, Sen Xiang, Fuli Zhao. Hedgehog signaling activation required for glypican-6-mediated regulation of invasion, migration, and epithelial–mesenchymal transition of gastric cancer cellsBioscience Reports 2020; 40(6) doi: 10.1042/BSR20193181